NECTIN3 and neoplasm: Pancreatic neuroendocrine tumors (PanNET) were studied by Hirabayashi et al., whose findings suggested that a loss of nectin-3 expression was an indicator of tumor aggressiveness—larger size, G2/3, higher Ki67, lymph node metastasis, more advanced disease stage.